Trial Outcomes & Findings for TAPP Inguinal Hernia Repair With Self-fixating Parietex™ ProGrip™ Mesh (NCT NCT01481376)
NCT ID: NCT01481376
Last Updated: 2016-01-07
Results Overview
Recurrence is defined as a clinically manifest bulge or a protrusion exacerbated by a Valsalva maneuver in the operated groin. The recurrence symptoms are assessed by phone based on the Symptoms Questionnaire and the recurrence diagnosis is confirmed during a physical examination by a physician.
COMPLETED
200 participants
At least 12 months post-surgery
2016-01-07
Participant Flow
Participant milestones
| Measure |
Parietex Progrip
Surgical cure of inguinal hernia using the Parietex™ ProGrip™ mesh by Laparoscopic Transabdominal Preperitoneal (TAPP) approach
|
|---|---|
|
Overall Study
STARTED
|
200
|
|
Overall Study
COMPLETED
|
169
|
|
Overall Study
NOT COMPLETED
|
31
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
TAPP Inguinal Hernia Repair With Self-fixating Parietex™ ProGrip™ Mesh
Baseline characteristics by cohort
| Measure |
Parietex Progrip
n=169 Participants
Surgical cure of inguinal hernia using the Parietex™ ProGrip™ mesh by Laparoscopic Transabdominal Preperitoneal (TAPP) approach
|
|---|---|
|
Age, Continuous
|
54.7 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
13 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
156 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: At least 12 months post-surgeryRecurrence is defined as a clinically manifest bulge or a protrusion exacerbated by a Valsalva maneuver in the operated groin. The recurrence symptoms are assessed by phone based on the Symptoms Questionnaire and the recurrence diagnosis is confirmed during a physical examination by a physician.
Outcome measures
| Measure |
Parietex Progrip
n=169 Participants
Surgical cure of inguinal hernia using the Parietex™ ProGrip™ mesh by Laparoscopic Transabdominal Preperitoneal (TAPP) approach
|
|---|---|
|
Proportion of Subjects Who Experience Hernia Recurrence (Defect Treated Initially With Parietex™ ProGrip™) Within 12 Months Post-surgery.
|
3 participants
|
SECONDARY outcome
Timeframe: 12 month post-operativelyOutcome measures
| Measure |
Parietex Progrip
n=168 Participants
Surgical cure of inguinal hernia using the Parietex™ ProGrip™ mesh by Laparoscopic Transabdominal Preperitoneal (TAPP) approach
|
|---|---|
|
Incidence of Groin Pain (Pain Score 0-10)
No/Low Pain (score 0-3)
|
160 participants
|
|
Incidence of Groin Pain (Pain Score 0-10)
Mild pain (Score 4-6)
|
6 participants
|
|
Incidence of Groin Pain (Pain Score 0-10)
Severe (score 7-10)
|
2 participants
|
SECONDARY outcome
Timeframe: The day of the discharge (an expected average of 1 day), 1month and at least 12 month post-operativelyOutcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: up to 12 monthsOutcome measures
| Measure |
Parietex Progrip
n=169 Participants
Surgical cure of inguinal hernia using the Parietex™ ProGrip™ mesh by Laparoscopic Transabdominal Preperitoneal (TAPP) approach
|
|---|---|
|
Postoperative Complications Including, Infection, Seroma, Hematoma, Visceral Adherence, Allergy Etc
Hematoma/Seroma
|
3 participants
|
|
Postoperative Complications Including, Infection, Seroma, Hematoma, Visceral Adherence, Allergy Etc
Emphysema in the inguinal regions (both sides)
|
1 participants
|
|
Postoperative Complications Including, Infection, Seroma, Hematoma, Visceral Adherence, Allergy Etc
Secondary hemorrhage through the trocar's site
|
2 participants
|
|
Postoperative Complications Including, Infection, Seroma, Hematoma, Visceral Adherence, Allergy Etc
Hematuria
|
1 participants
|
|
Postoperative Complications Including, Infection, Seroma, Hematoma, Visceral Adherence, Allergy Etc
Swelling above the genital organs
|
1 participants
|
SECONDARY outcome
Timeframe: at least 12 month post-operativelyOutcome measures
| Measure |
Parietex Progrip
n=169 Participants
Surgical cure of inguinal hernia using the Parietex™ ProGrip™ mesh by Laparoscopic Transabdominal Preperitoneal (TAPP) approach
|
|---|---|
|
Patient Satisfaction
Very satisfied/Satisfied
|
162 participants
|
|
Patient Satisfaction
Neutral
|
2 participants
|
|
Patient Satisfaction
Unsatisfied/Very unsatisfied
|
5 participants
|
SECONDARY outcome
Timeframe: From skin incision to closure (The expected median operating time is 36 minutes for unilateral and 50 minutes for bilateral repair)Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Duration of the hospital stay (expected average of 1 day)Outcome measures
| Measure |
Parietex Progrip
n=169 Participants
Surgical cure of inguinal hernia using the Parietex™ ProGrip™ mesh by Laparoscopic Transabdominal Preperitoneal (TAPP) approach
|
|---|---|
|
Hospital Length of Stay
|
2.1 Days
Standard Deviation 0.8
|
Adverse Events
Parietex Progrip
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Docteur Dieter BIRK
Surgical Department of the Protestant Hospital
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: LTE60